로딩 중…
StockDiggingStockDigging

Illumina, Inc.

ILMN· NASDAQ
$239.55-2.30%
2026-09-18

Financials

Valuation Metrics

Illumina, Inc.'s Market Cap is $36.24B. At end of 2025 it was $20.07B. Ranked #397 of 3,121 in US market (top 13%), #112 of 1,463 on NASDAQ (top 8%), #25 of 205 in Health Care Equipment & Services (top 12%) by Market Cap.

Investment Metrics(as of 2026-09-18)

MetricValue
Size
Market Cap$36.24B
Revenue$4.49B
Net Income$825M
Total Assets$6.65B
Net Assets$2.84B
Employees8,600
Value
P/E43.93x
P/B12.77x
P/S8.07x
EV/EBITDA27.68x
FCF Yield2.59%
Profitability
ROE29.07%
ROA12.41%
Op. Margin20.97%
Revenue Growth4.93%
Earnings Growth-34.42%
Financial Health
Debt Ratio134.32%
Total Debt$2.53B
FCF$939M
Cash$1.04B
Current Ratio1.80x
Net Debt/EBITDA1.09x
Performance
1Y Return132.51%
1M Return16.85%
From 52W High-3.87%
1Y MDD-25.66%
Trading
Volume2,777,825 shares
Trading Value$671M
Per Share
EPS$5.45
BPS$18.76

Company Info

CEO Mr. Jacob Thaysen Ph.D.
Employees 8,600
HQ San Diego, United States

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.